Company: LRHC
Filing Date: 2025-11-24
Form Type: PRE 14C
Source: 0001213900-25-113797
Chunk: 6

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-24
Form: PRE 14C
Chunk 6
---
 taking action by written consent under Section 78.320 of the NRS.

The Majority Stockholders’
consent (the “Majority Stockholders Consent”) we have received constitutes the only stockholder approval required under
the NRS, Nasdaq Listing Rules 5635(b) and 5635(d) (as applicable to the first Corporate Action listed above), our
Articles of Incorporation and our Bylaws, to approve the Corporate Actions. Our Board of Directors is not soliciting your consent or your
proxy in connection with Corporate Actions and neither consents, nor proxies are being requested from stockholders.

This Information Statement
is being distributed pursuant to the requirements of Section 14(c) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to our stockholders of record on the Record Date. The actions approved by the Majority Stockholders will be effective
no earlier than twenty (20) days after the date this Information Statement is first mailed or otherwise delivered to holders of our Common
Stock as of the Record Date, which we expect to be on or about [*], 2025. Stockholders may also request a copy of the Information Statement
by contacting our main office at (321) 250-1799.

The entire cost of furnishing
this Information Statement will be borne by us. We will request brokerage houses, nominees, custodians, fiduciaries and other like parties
to forward this Information Statement to the beneficial owners of our voting securities held of record by them and we will reimburse such
persons for out-of-pocket expenses incurred in forwarding such material.

<div align='center'>WE ARE NOT ASKING YOU FOR A PROXY, AND

YOU ARE REQUESTED NOT TO SEND US A PROXY.

2

ACTIONS TAKEN</div>

This Information Statement
contains a brief summary of the material aspects of the Corporate Actions approved by the members of the Board of Directors and the Majority
Stockholders.

1.APPROVAL OF THE ISSUANCE OF ALL NOTES AND CONVERSION SHARES IN EXCESS OF 19.99% OF THE COMPANY’S ISSUED AND OUTSTANDING COMMON STOCK AT A PRICE LESS THAN THE MINIMUM PRICE

On November 12, 2025 (the
“Signing Date”), the Company and certain institutional accredited investors (the “Investors”) entered
into a Securities Purchase Agreement (the “Securities Purchase Agreement”), pursuant to which the Company agreed to
issue and sell, and the Investors agreed to purchase, in